Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review.
Saved in:
| Title: | Parameter Space and Potential for Biomarker Development in 25 Years of fMRI Drug Cue Reactivity: A Systematic Review. |
|---|---|
| Authors: | Sangchooli A; Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Australia., Zare-Bidoky M; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis.; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Fathi Jouzdani A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Schacht J; Department of Psychiatry, University of Colorado School of Medicine, Aurora., Bjork JM; Institute for Drug and Alcohol Studies, Department of Psychiatry, Virginia Commonwealth University, Richmond., Claus ED; Department of Biobehavioral Health, The Pennsylvania State University, University Park., Prisciandaro JJ; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Wilson SJ; Department of Psychology, The Pennsylvania State University, State College., Wüstenberg T; Field of Focus IV, Core Facility for Neuroscience of Self-Regulation (CNSR), Heidelberg University, Heidelberg, Germany., Potvin S; Department of Psychiatry and Addiction, Université de Montréal, Montréal, Quebec, Canada., Ahmadi P; Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada., Bach P; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Baldacchino A; School of Medicine, University of St Andrews, St Andrews, Scotland., Beck A; Faculty of Health, Health and Medical University, Potsdam, Germany.; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany., Brady KT; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Brewer JA; Department of Behavioral and Social Sciences, Brown University School of Public Health, Providence, Rhode Island., Childress AR; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Courtney KE; Department of Psychiatry, University of California, San Diego., Ebrahimi M; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Filbey FM; Center for BrainHealth, School of Behavioral and Brain Sciences, University of Texas at Dallas., Garavan H; Department of Psychiatry, University of Vermont, Burlington., Ghahremani DG; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Goldstein RZ; Departments of Psychiatry and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, New York., Goudriaan AE; Department of Psychiatry, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, the Netherlands.; Amsterdam Neuroscience, Amsterdam, the Netherlands., Grodin EN; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Hanlon CA; Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, North Carolina.; BrainsWay Inc, Winston-Salem, North Carolina., Haugg A; Department of Child and Adolescent Psychiatry and Psychotherapy, Psychiatric University Hospital Zurich, University of Zurich, Zurich, Switzerland., Heilig M; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Heinz A; Department of Psychiatry and Neurosciences, Charité Campus Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany., Holczer A; Department of Neurology, Albert Szent-Györgyi Health Centre, University of Szeged, Szeged, Hungary., Van Holst RJ; Amsterdam Institute for Addiction Research, Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands., Joseph JE; Department of Neuroscience, Medical University of South Carolina, Charleston., Juliano AC; Department of Psychiatry, University of Vermont, Burlington., Kaufman MJ; McLean Hospital, Harvard Medical School, Belmont, Massachusetts., Kiefer F; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Khojasteh Zonoozi A; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Kuplicki RT; Laureate Institute for Brain Research, Tulsa, Oklahoma., Leyton M; Department of Psychiatry, McGill University, Montreal, Quebec, Canada., London ED; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Mackey S; Department of Psychiatry, University of Vermont, Burlington., McClernon FJ; Department of Psychiatry and Behavioral Sciences, Duke University, Durham, North Carolina., Mellick WH; Addiction Sciences Division, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston., Morley K; Specialty of Addiction Medicine, Faculty of Medicine and Health, Sydney Medical School, University of Sydney, Sydney, Australia., Noori HR; McGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge., Oghabian MA; Neuroimaging and Analysis Group, Research Center for Molecular and Cellular Imaging, Tehran University of Medical Sciences, Tehran, Iran., Oliver JA; TSET Health Promotion Research Center, University of Oklahoma Health Sciences Center, Oklahoma City., Owens M; Department of Psychiatry, University of Vermont, Burlington., Paulus MP; Laureate Institute for Brain Research, Tulsa, Oklahoma., Perini I; Center for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden., Rafei P; Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran., Ray LA; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles., Sinha R; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Smolka MN; Department of Psychiatry, Technische Universität Dresden, Dresden, Germany., Soleimani G; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis., Spanagel R; Institute of Psychopharmacology, Central Institute of Mental Health, Mannheim, Germany., Steele VR; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Tapert SF; Department of Psychiatry, University of California, San Diego., Vollstädt-Klein S; Department of Addictive Behaviour and Addiction Medicine, Central Institute of Mental Health (CIMH), Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Wetherill RR; Perelman School of Medicine, University of Pennsylvania, Philadelphia., Witkiewitz K; Department of Psychology, University of New Mexico, Albuquerque., Yuan K; School of Life Science and Technology, Xidian University, Xi'an, China., Zhang X; Department of Psychology, School of Humanities and Social Science, University of Science and Technology of China, Anhui, China., Verdejo-Garcia A; Turner Institute for Brain and Mental Health, Monash University, Clayton, Australia., Potenza MN; Department of Psychiatry, Technische Universität Dresden, Dresden, Germany., Janes AC; Cognitive and Pharmacological Neuroimaging Unit, National Institute on Drug Abuse, Baltimore, Maryland., Kober H; Department of Psychiatry, Yale School of Medicine, New Haven, Connecticut., Zilverstand A; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis., Ekhtiari H; Department of Psychiatry and Behavioral Sciences, University of Minnesota, Minneapolis.; Laureate Institute for Brain Research, Tulsa, Oklahoma. |
| Corporate Authors: | Addiction Cue-Reactivity Initiative (ACRI) Network |
| Source: | JAMA psychiatry [JAMA Psychiatry] 2024 Apr 01; Vol. 81 (4), pp. 414-425. |
| Publication Type: | Systematic Review; Journal Article |
| Journal Info: | Publisher: American Medical Association Country of Publication: United States NLM ID: 101589550 Publication Model: Print Cited Medium: Internet ISSN: 2168-6238 (Electronic) Linking ISSN: 2168622X NLM ISO Abbreviation: JAMA Psychiatry |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2168-6238 |
|---|---|
| DOI: | 10.1001/jamapsychiatry.2023.5483 |
